Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Nature Publishing Group full text link Nature Publishing Group Free PMC article
Full text links

Actions

Share

.2024 Feb 3;15(1):1030.
doi: 10.1038/s41467-024-45436-3.

Secretin-dependent signals in the ventromedial hypothalamus regulate energy metabolism and bone homeostasis in mice

Affiliations

Secretin-dependent signals in the ventromedial hypothalamus regulate energy metabolism and bone homeostasis in mice

Fengwei Zhang et al. Nat Commun..

Abstract

Secretin, though originally discovered as a gut-derived hormone, is recently found to be abundantly expressed in the ventromedial hypothalamus, from which the central neural system controls satiety, energy metabolism, and bone homeostasis. However, the functional significance of secretin in the ventromedial hypothalamus remains unclear. Here we show that the loss of ventromedial hypothalamus-derived secretin leads to osteopenia in male and female mice, which is primarily induced by diminished cAMP response element-binding protein phosphorylation and upregulation in peripheral sympathetic activity. Moreover, the ventromedial hypothalamus-secretin inhibition also contributes to hyperphagia, dysregulated lipogenesis, and impaired thermogenesis, resulting in obesity in male and female mice. Conversely, overexpression of secretin in the ventromedial hypothalamus promotes bone mass accrual in mice of both sexes. Collectively, our findings identify an unappreciated secretin signaling in the central neural system for the regulation of energy and bone metabolism, which may serve as a new target for the clinical management of obesity and osteoporosis.

© 2024. The Author(s).

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Systemic SCT or SCTR KO results in metabolic dysfunction and bone loss.
a Daily food intake of 10-week-old WT, Sct−/−, and Sctr−/− mice. Cumulative (b) and total (c) rebound food intake of 10-week-old WT, Sct−/−, and Sctr−/− mice after 16 h overnight fasting.d Weekly body weight changes of 4- to 20-week-old WT, Sct−/−, and Sctr−/− mice fed on standard rodent chow.e Body composition of 18-week-old WT, Sct−/−, and Sctr−/− mice.f Temporal changes of VO2 and VCO2 in 16-week-old WT, Sct−/−, and Sctr−/− mice.g Temporal changes of EE in 16-week-old WT, Sct−/−, and Sctr−/− mice (night: F(2, 12) = 10.408, WTvs Sct−/− (**Pgenotype = 0.0022), WTvs Sctr−/− (**Pgenotype = 0.0028); day: F(2, 12) = 0.916, WTvs Sct−/− (Pgenotype = 0.1737), WTvs Sctr−/− (Pgenotype = 0.3896)).h Serum NE levels in 20-week-old WT, Sct−/−, and Sctr−/− mice.i Representative μCT and H&E staining images showing the reduction in trabecular bone mass in the femurs of 20-week-old Sct−/− and Sctr−/− mice. Scale bar = 250 μm.j Corresponding measurements of (i): trabecular bone volume fraction (BV/TV), bone mineral density (BMD of TV), trabecular number (Tb.N), trabecular thickness (Tb.Th), trabecular pattern factor (Tb.Pf), trabecular separation (Tb.Sp), and specific bone surface (BS/BV). BW, body weight. Numbers in parentheses in each graph indicate sample size. Box plots with whiskers from minima to maxima, the central line at the 50th percentile, and the ends of the box at the 25th and 75th percentiles.a,d,e,f Two-way ANOVA with Holm–Šídák multiple comparisons test.c,h,j One-way ANOVA with Holm–Šídák multiple comparisons test.g One-way ANCOVA with pairwise comparisons on adjusted means. *P < 0.05; **P < 0.01; ***P < 0.001. Error bars represent SEM. Source data are provided as a Source Data file.
Fig. 2
Fig. 2. VMH-derived SCT regulate bone mass via SNS.
a RNAscope in situ hybridization ofSct andNr5a1 in the VMH sections (n = 3). Scale bars = 50 μm.b Venn diagram of theSct- andNr5a1-positive cell distributions in (a).c Immunostaining of SCT in the VMH sections (n = 3). Scale bars = 100 μm.d Left: schematic of injecting AAV-ShSCT-eGFP/AAV-ShControl-eGFP bilaterally into the VMH of C57BL6/N mice. Right: representative image of eGFP expression in VMH (n = 5). Scale bars = 100 μm.e Reduced transcript levels ofSct in VMH after shRNA-mediated SCT KD.f Representative μCT images of femurs from 20-week-old ShSCT and ShCon littermates.g Corresponding measurements of (f). Representative femoral H&E staining (h) and lipid droplet statistics (i) of 20-week-old ShSCT and ShCon littermates. Arrows indicate lipids in bone marrow. Scale bar = 250 μm.j Left: TRAP staining of trabecular bone of 20-week-old ShSCT and ShCon littermates. Right: quantification of osteoclasts on the bone surface. Scale bars = 100 μm.k Left: calcein double labeling in trabecular bone. Right: MAR of 20-week-old ShSCT and ShCon littermates. Scale bar = 50 μm.l Left: schematic of injecting AAV-Cre-eGFP/AAV-eGFP bilaterally into the VMH of Sctfl/fl mice. Right: representative image of eGFP expression in VMH (n = 5). Scale bar = 100 um.m Representative μCT images of femurs from 20-week-old SCTVMH−/− and eGFP littermates.n Representative femoral H&E staining images of 20-week-old SCTVMH−/− and eGFP littermates (n = 5). Arrows indicate lipids in bone marrow. Scale bar = 250 um.o, Corresponding measurements of (m).p Western blot of pCREB in VMH of 20-week-old ShSCT and ShCon littermates.q Serum NE levels of ShSCT and ShCon littermates. Numbers in parentheses in each graph indicate sample size. Box plots with whiskers from minima to maxima, the central line at the 50th percentile, and the ends of the box at the 25th and 75th percentiles. Two-tailed Student’st-test. *P < 0.05; **P < 0.01; ***P < 0.001. Error bars represent SEM. Source data are provided as a Source Data file.
Fig. 3
Fig. 3. Conditional KD of SCT in VMH leads to hyperphagia and obesity.
a Daily food intake of 10-week-old ShSCT and ShCon littermates.b Rebound food intake of 10-week-old overnight fasted ShSCT and ShCon littermates.c Cumulative (left) and total (right) rebound food intake after SCT administration in 10-week-old overnight fasted ShSCT and ShCon littermates.d HypothalamicAgrp andPomc expression of 20-week-old ShSCT and ShCon littermates.e Left: weekly body weight changes of ShSCT and ShCon littermates fed on standard rodent chow. Black arrow indicates virus injection at 7 weeks of age. Right: representative photographs of 20-week-old mice.f Body composition of ShSCT and ShCon littermates.g WAT mass fractions of ShSCT and ShCon littermates.h Left: H&E staining of iWAT from ShSCT and ShCon littermates (n = 5). Right: adipocyte surface area distribution of iWAT. Scale bar = 100 μm.i Relative expression of beige adipocyte marker genes in the iWAT.j Blood insulin levels of ShSCT and ShCon littermates.k,l Glucose tolerance test of ShSCT and ShCon littermates.m,n Insulin tolerance test of ShSCT and ShCon littermates.o Daily food intake of 10-week-old SCTVMH−/− and eGFP littermates.p Rebound food intake of 10-week-old overnight fasted SCTVMH−/− and eGFP littermates.q Left: weekly body weight changes of SCTVMH−/− and eGFP littermates fed on standard rodent chow. Black arrow indicates virus injection at 7 weeks of age. Right: representative photographs of 20-week-old mice.r Body composition of SCTVMH−/− and eGFP littermates. AUC, area under the curve. Numbers in parentheses in each graph indicate sample size. Box plots with whiskers from minima to maxima, the central line at the 50th percentile, and the ends of the box at the 25th and 75th percentiles.a,b,e,f,k,m,or Two-way ANOVA with Holm–Šídák multiple comparisons test. (c) One-way ANOVA with Holm–Šídák multiple comparisons test.d,g,i,j,l,n Two-tailed Student’st-test. *P < 0.05; **P < 0.01; ***P < 0.001. Error bars represent SEM. Source data are provided as a Source Data file.
Fig. 4
Fig. 4. Conditional KD of SCT in VMH leads to thermogenic dysfunction.
a Temporal changes of VO2 and VCO2 in 16-week-old ShSCT and ShCon littermates.b Temporal changes of EE in 16-week-old ShSCT and ShCon littermates.c Temporal changes of motor activity in 16-week-old ShSCT and ShCon littermates.d H&E staining of iBAT. Scale bar = 100 μm.e Mitochondria DNA contents in iBAT.f Relative expression of thermogenesis-related genes in iBAT.g The concentration (left) and total amount (right) of Ucp1 protein in iBAT depot.h Relative expression of inflammatory cytokine genes in iBAT.i Relative expression of sympathetic innervation-related genes in iBAT.j Western blot of TH in iBAT. XAMB, ambulatory activity count. XTOT, total horizontal motor activity. ZTOT, total vertical motor activity. Numbers in parentheses in each graph indicate sample size. Box plots with whiskers from minima to maxima, the central line at the 50th percentile, and the ends of the box at the 25th and 75th percentiles.a,c Two-way ANOVA with Holm–Šídák multiple comparisons test.b One-way ANCOVA with pairwise comparisons on adjusted means.ej Two-tailed Student’st-test. *P < 0.05; **P < 0.01; ***P < 0.001. Error bars represent SEM. Source data are provided as a Source Data file.
Fig. 5
Fig. 5. Conditional KD of SCTR in VMH leads to osteopenia, hyperphagia, and obesity.
a Double-immunostaining of SCTR and GFAP in the VMH sections (n = 5). Scale bar = 100 μm.b Left: schematic of injecting AAV-Cre- eGFP/AAV-eGFP bilaterally into the VMH of Sctrfl/fl mice. Right: representative image of eGFP expression in VMH (n = 5). Scale bar = 100 μm.c Reduced transcript levels ofSctr in VMH after Cre-mediated SCTR KD.d Representative μCT images of femurs from 20-week-old SCTRVMH−/− and eGFP littermates.e Corresponding measurements of (d).f Representative femoral H&E staining images of 20-week-old SCTRVMH−/− and eGFP littermates. Scale bar = 250 μm.g Left: calcein double labeling in trabecular bone. Right: MAR of 20-week-old SCTRVMH−/− and eGFP littermates. Scale bar = 50 μm.h Serum NE levels of SCTRVMH−/− and eGFP littermates.i Daily food intake of 10-week-old SCTRVMH−/− and eGFP littermates.j Rebound food intake of 10-week-old overnight fasted SCTRVMH−/− and eGFP littermates.k Left: weekly body weight changes of SCTRVMH−/− and eGFP littermates fed on standard rodent chow. Black arrow indicates virus injection at 7 weeks of age. Right: representative photographs of 20-week-old mice.l Body composition of 18-week-old SCTRVMH−/− and eGFP littermates. Numbers in parentheses in each graph indicate sample size. Box plots with whiskers from minima to maxima, the central line at the 50th percentile, and the ends of the box at the 25th and 75th percentiles.c,e,g,h Two-tailed Student’st-test.il Two-way ANOVA with Holm–Šídák multiple comparisons test. *P < 0.05; **P < 0.01; ***P < 0.001. Error bars represent SEM. Source data are provided as a Source Data file.
Fig. 6
Fig. 6. Conditional KD of SCT in the VMH exacerbates obesity and osteopenia in DIO mice.
a Left: weekly body weight changes of SCTVMH−/− and eGFP littermates fed on HFD. Black arrow indicates virus injection at 7 weeks of age. The yellow shaded area indicates that the mice were fed HFD. Right: representative photographs of 20-week-old mice.b Body composition of 18-week-old HFD-fed SCTVMH−/− and eGFP littermates.c Serum leptin levels in HFD-fed SCTVMH−/− and eGFP littermates.d Daily food intake of 16-week-old HFD-fed SCTVMH−/− and eGFP littermates.e Serum NE levels in HFD-fed SCTVMH−/− and eGFP littermates.f Temporal changes of VCO2 and VO2 in 16-week-old HFD-fed SCTVMH−/− and eGFP littermates.g Temporal changes of EE in 16-week-old HFD-fed SCTVMH−/− and eGFP littermates.h Temporal changes of motor activity in 16-week-old HFD-fed SCTVMH−/− and eGFP littermates.i Representative μCT images of femurs from 20-week-old HFD-fed SCTVMH−/− and eGFP littermates.j Corresponding measurements of (i).k Representative femoral H&E staining images of 20-week-old HFD-fed SCTVMH−/− and eGFP littermates. Scale bar = 250 μm. Numbers in parentheses in each graph indicate sample size. Box plots with whiskers from minima to maxima, the central line at the 50th percentile, and the ends of the box at the 25th and 75th percentiles.a,b,d,f,h Two-way ANOVA with Holm–Šídák multiple comparisons test.c,e,j Two-tailed Student’st-test.g One-way ANCOVA with pairwise comparisons on adjusted means. *P < 0.05; **P < 0.01; ***P < 0.001. Error bars represent SEM. Source data are provided as a Source Data file.
Fig. 7
Fig. 7. SCT overexpression in VMH leads to bone mass increment.
a Left: schematic of injecting rAAV-EF1α-SCT-mCherry or rAAV-EF1α-mCherry bilaterally into the VMH of C57BL6/N mice. Right: representative image of mCherry expression in VMH (n = 5). Scale bars = 100 μm.b Enhanced SCT levels in VMH after EF1α-mediated SCT overexpression.c Serum NE levels in SCToe and mCherry littermates.d Western blot of pCREB in VMH of 20-week-old SCToe and mCherry littermates.e Representative μCT images of femurs from 20-week-old SCToe and mCherry littermates.f Corresponding measurements of (e).g Representative femoral H&E staining images of 20-week-old SCToe and mCherry littermates. Scale bar = 250 μm.h Left: TRAP staining of trabecular bone of 20-week-old SCToe and mCherry littermates. Right: quantification of osteoclasts on the bone surface. Scale bars = 100 μm.i Daily food intake of 10-week-old SCToe and mCherry littermates.j Rebound food intake of 10-week-old overnight fasted SCToe and mCherry littermates.k Weekly body weight changes of SCToe and mCherry littermates fed on standard rodent chow. Black arrow indicates virus injection at 7 weeks of age.l Body composition of 18-week-old SCToe and mCherry littermates.m The schematic shows the mechanism by which VMH-derived SCT signaling regulates skeletal and metabolic homeostasis. Numbers in parentheses in each graph indicate sample size. Box plots with whiskers from minima to maxima, the central line at the 50th percentile, and the ends of the box at the 25th and 75th percentiles. (b,c,d,f,h) Two-tailed Student’st-test. (i,j,k,l) Two-way ANOVA with Holm–Šídák multiple comparisons test. *P < 0.05; **P < 0.01; ***P < 0.001. Error bars represent SEM. Source data are provided as a Source Data file.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Bayliss WM, Starling EH. The mechanism of pancreatic secretion. J. Physiol. 1902;28:325–353. doi: 10.1113/jphysiol.1902.sp000920. - DOI - PMC - PubMed
    1. Cheng CY, Chu JY, Chow BK. Central and peripheral administration of secretin inhibits food intake in mice through the activation of the melanocortin system. Neuropsychopharmacology. 2011;36:459–471. doi: 10.1038/npp.2010.178. - DOI - PMC - PubMed
    1. Chu JY, Cheng CY, Sekar R, Chow BK. Vagal afferent mediates the anorectic effect of peripheral secretin. PLoS ONE. 2013;8:e64859. doi: 10.1371/journal.pone.0064859. - DOI - PMC - PubMed
    1. Laurila S, et al. Secretin activates brown fat and induces satiation. Nat. Metab. 2021;3:798–809. doi: 10.1038/s42255-021-00409-4. - DOI - PubMed
    1. Li Y, et al. Secretin-activated brown fat mediates prandial thermogenesis to induce satiation. Cell. 2018;175:1561–1574.e1512. doi: 10.1016/j.cell.2018.10.016. - DOI - PubMed

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full text links
Nature Publishing Group full text link Nature Publishing Group Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp